Services
- Biosafety
  
  Cell Therapy
  
  Gene Therapy
  
  Human or Animal origin Products
  
  Viral Clearance
  
  GMP Cell Banking
  
  Research Cell Banking
  
  Medical Devices
  
  BioAssays in vitro
  
  BioAssays in vivo
  
  Toxicology
- Recombinant Proteins or mAbs
  Cell Therapy
  Gene Therapy
  Viral Vaccines
  Human or Animal Products
  
  BioSafety
  
  For more than 30 years, whatever the material you are working on, Texcell provides you state-of-art services to ensure the safety and security of your material and processes.
  
  Study Tiers to Consider
  Levels of Service
  Virus Panel / HEV
  Prion Clearance Studies
  
  Viral Clearance
  
  Meet with Texcell the viral clearance requirements for all your biologicals from development phases, BLA or first clinical studies in humans up to IND and pivotal clinical trials.
  
  Cell Identity
  Mycoplasma testing
  Sterility
  MCB and RCB manufacturing
  
  GMP Cell Banking
  
  With its platforms, technologies and personnel, Texcell is the place of choice to develop efficient and cost-effective MCB and WCB under GMP rules.
  
  Cell Line Generation
  Cell Line Expansion
  Clonal Selection
  Research Cell Banking
  Virus Propagation
  
  Research Cell Banking
  
  Texcell provides outstanding cell banking expertise and facilities for your cell characterization, cell expansion and cell banking projects.
  
  Medical Devices
  
  Medical Devices
  
  Test the biological response to your medical devices according to ISO 10993 with in vitro and ex vivo test methods in compliance with the GLP standards.
  
  Biomarkers Expression
  Cytokines Expression
  Potency Assays
  
  Bioassays in vitro
  
  Texcell Immunology lab offers you a wide panel of assays for the evaluation of the immune response for biologicals, from serological quantification to in vitro cellular assays.
  
  Biodistribution / Shedding
  Immunigenicity
  Potency Assays
  Tumorigenicity
  
  Bioassays in vivo
  
  A broad range of tests can be performed on your samples to assess immunogenicity, biosimilarity, tumorogenicity, adventitious viruses.
  
  Toxicology
  
  Toxicology
  
  Toxicity tests on biologicals or food additives are performed in accordance with the OECD guidelines and with the recent guidance for submission for food additive evaluations of EFSA.
About Us
Careers
Contact Us

News

TEXCELL acquires German company Vivo Science GmbH

May 17, 2016 | News | Yves Barbier

TEXCELL and ATRI in cooperation agreement

April 27, 2016 | News | Yves Barbier

Press release TEXCELL and ATRI in cooperation agreement Evry/Taipei, April 22nd 2016 TEXCELL of France and ATRI (Agricultural Technology Research Institute) in Taiwan announce a strategic partnership aimed at offering viral safety service solutions to biotech and... Read More

2nd annual conference on IMMUNOGENICITY – 29 & 30 June 2015, London, UK

June 18, 2015 | News | Yves Barbier

Texcell will be attending at the 2nd annual conference on Immunogenicity in London Meet us or contact us at info@texcell.fr to request a meeting to discuss about oppportunities of collaboration. Read More

Viral Safety & Raw Materials Congress – 24 & 25 June 2015 Vienna, Austria

June 17, 2015 | News | Yves Barbier

Texcell will be attending Viral Safety & Raw Materials Congress Meet our team at our booth n°12 or contact us at info@texcell.fr to request a meeting to discuss about oppportunities of collaboration. Read More

Bio2015 International Convention – Texcell Booth #301

June 2, 2015 | News | Francois NICOLAS

http://convention.bio.org/2015/ Read More